Summary of Key Points Core Viewpoint - 康臣药业 has been actively repurchasing its shares, indicating a strategy to support its stock price amidst recent declines [2]. Share Buyback Details - On November 4, 康臣药业 repurchased 495,000 shares at a price range of HKD 14.460 to HKD 14.910, totaling HKD 7.3134 million [2]. - The stock closed at HKD 14.890 on the same day, reflecting a decrease of 1.26% with a total trading volume of HKD 35.1134 million [2]. - Since October 14, the company has conducted buybacks for 15 consecutive days, acquiring a total of 3.696 million shares for a cumulative amount of HKD 56.0194 million, during which the stock price has dropped by 6.94% [2]. - Year-to-date, 康臣药业 has executed 33 buybacks, totaling 8.891 million shares and an aggregate amount of HKD 115 million [2]. Buyback Transaction Summary - A detailed table of buyback transactions shows the number of shares repurchased, highest and lowest prices, and total amounts for each transaction from July to November 2025 [3].
康臣药业(01681.HK)连续15日回购，累计斥资5601.94万港元